Triple

Target class: GIP receptor agonist
Context triple: [Mounjaro, instanceOf, GIP receptor agonist]

• A. G protein–coupled receptor
  A G protein–coupled receptor is a membrane-spanning protein that detects extracellular signals and activates intracellular G proteins to trigger specific cellular responses.
• B. cannabinoid receptor
  A cannabinoid receptor is a cell-surface G protein–coupled receptor that binds endogenous, plant-derived, or synthetic cannabinoids to modulate processes such as pain perception, appetite, mood, and immune function.
• C. pegylated interferon beta-1a
  Pegylated interferon beta-1a is a long-acting, pegylated form of interferon used as a disease-modifying therapy to reduce relapses and slow progression in patients with relapsing forms of multiple sclerosis.
• D. Bruton tyrosine kinase inhibitor
  A Bruton tyrosine kinase inhibitor is a targeted small-molecule drug that blocks BTK signaling in B cells to disrupt pathways critical for their activation, proliferation, and survival, primarily used in the treatment of certain B-cell malignancies and autoimmune diseases.
• E. antisense oligonucleotide
  An antisense oligonucleotide is a short, synthetic strand of nucleic acid designed to bind specifically to a target RNA sequence and modulate its function, typically to alter gene expression for therapeutic purposes.
• F. None of above. chosen